Jonathan C. Fox

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan C. Fox:

Company Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. Director Common Stock 24,175 $569,563 $23.56 02 Jan 2026 Direct
Edgewise Therapeutics, Inc. Director Stock Option (Right to Buy) 30,000 16 Jun 2025 Direct

Insider Reports Filed by Jonathan C. Fox

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EWTX Edgewise Therapeutics, Inc. 02 Jan 2026 1 $0 4 Director 05 Jan 2026, 17:33
EWTX Edgewise Therapeutics, Inc. 11 Nov 2025 1 +$199,403 4 Director 13 Nov 2025, 18:04
EWTX Edgewise Therapeutics, Inc. 01 Oct 2025 1 $0 4 Director 02 Oct 2025, 20:29
EWTX Edgewise Therapeutics, Inc. 01 Jul 2025 1 $0 4 Director 02 Jul 2025, 16:18
EWTX Edgewise Therapeutics, Inc. 16 Jun 2025 1 $0 4 Director 18 Jun 2025, 19:36
EWTX Edgewise Therapeutics, Inc. 01 Apr 2025 1 $0 4 Director 03 Apr 2025, 18:11
EWTX Edgewise Therapeutics, Inc. 10 Jun 2024 1 $0 4 Director 12 Jun 2024, 19:32
EWTX Edgewise Therapeutics, Inc. 26 Dec 2023 1 +$100,958 4 Director 28 Dec 2023, 16:39
EWTX Edgewise Therapeutics, Inc. 12 Jun 2023 1 $0 4 Director 14 Jun 2023, 19:30
EWTX Edgewise Therapeutics, Inc. 03 Mar 2023 1 $0 4 Director 07 Mar 2023, 16:59
EWTX Edgewise Therapeutics, Inc. 02 Mar 2023 0 $0 3 Director 07 Mar 2023, 16:57